An Observational Study in Children and Adults With Stargardt Disease

Part of paid clinical trials in Dallas, Texas.

Sponsor
AAVantgarde Bio Srl
Study ID
NCT06591806
Status
Recruiting
Apply to this trial

Conditions

  • Stargardt Disease

Eligibility Criteria

Sex
ALL
Age
8 Years - 50 Years
Healthy Volunteers
Not accepted

Study Details

This multicenter, prospective, longitudinal, observational study in approximately 80 subjects with Stargardt disease secondary to biallelic mutations in the ABCA4 gene (STGD1) aims to evaluate prognostic factors of disease progression, and to further characterize the patient population for future clinical studies.

Key Dates

Start date
May 1, 2024
Status verified
Aug 2025
Primary completion
Jun 30, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
80 participants (estimated)

Primary Outcome Measure

To measure the change from baseline in Fundus Autofluorescence [ Time Frame: 24 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Retina Foundation of the SouthwestDallasTexas75231
Katherine Juroch
[email protected]

Find similar trials in Dallas, TX

By research site
Retina Foundation of the Southwest· Dallas, TX

Related Studies